Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-002045
Filing Date
2024-11-21
Accepted
2024-11-21 16:20:30
Documents
85
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q camp-20240930x10q.htm   iXBRL 10-Q 2167772
2 EX-31.1 camp-20240930xex31d1.htm EX-31.1 12750
3 EX-31.2 camp-20240930xex31d2.htm EX-31.2 12708
4 EX-32.1 camp-20240930xex32d1.htm EX-32.1 6536
5 EX-32.2 camp-20240930xex32d2.htm EX-32.2 6543
6 GRAPHIC camp-20240930x10q004.jpg GRAPHIC 9296
  Complete submission text file 0001410578-24-002045.txt   8198902

Data Files

Seq Description Document Type Size
7 EX-101.SCH camp-20240930.xsd EX-101.SCH 61274
8 EX-101.CAL camp-20240930_cal.xml EX-101.CAL 52892
9 EX-101.DEF camp-20240930_def.xml EX-101.DEF 173200
10 EX-101.LAB camp-20240930_lab.xml EX-101.LAB 491628
11 EX-101.PRE camp-20240930_pre.xml EX-101.PRE 375706
88 EXTRACTED XBRL INSTANCE DOCUMENT camp-20240930x10q_htm.xml XML 1246131
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42365 | Film No.: 241484690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)